Can Celecoxib Cause Kidney Disease?
Yes, celecoxib can cause acute kidney injury and worsen chronic kidney disease, particularly in high-risk patients with pre-existing renal impairment, heart failure, dehydration, or those taking diuretics, ACE inhibitors, or ARBs.
Mechanism and Risk Profile
Celecoxib, like all NSAIDs, reduces prostaglandin formation in a dose-dependent manner, which secondarily decreases renal blood flow and can precipitate overt renal decompensation 1. The FDA label explicitly warns that long-term NSAID administration has resulted in renal papillary necrosis and other renal injury 1.
The highest-risk patients include those with:
- Impaired baseline renal function
- Dehydration or hypovolemia
- Heart failure
- Liver dysfunction
- Concurrent use of diuretics, ACE inhibitors, or ARBs
- Elderly age 1
Clinical Evidence
A 2006 population-based study of 121,722 NSAID users found that celecoxib carried a borderline lower risk of acute renal failure within 30 days of initiation (RR = 1.54) compared to rofecoxib (RR = 2.31) and naproxen (RR = 2.42), though the risk remained significant 2. The risk was highest within the first 30 days of treatment initiation across all NSAIDs.
Multiple case reports document serious renal complications with celecoxib, including:
- Acute interstitial nephritis with eosinophilic infiltrate 3
- Minimal change disease with nephrotic-range proteinuria 4
- Acute renal failure requiring dialysis 5, 6
Importantly, discontinuation of celecoxib typically leads to recovery of renal function 1, though this is not guaranteed in all cases.
Comparative Safety
Recent evidence suggests celecoxib may have a more favorable renal safety profile than non-selective NSAIDs. A 2025 umbrella review found that celecoxib did not increase the risk of renal dysfunction or elevated creatinine compared to placebo or non-selective NSAIDs, and may be associated with fewer renal adverse events 7. Additionally, celecoxib does not decrease glomerular filtration rate in elderly patients or those with chronic renal failure 8.
Clinical Management Algorithm
Before initiating celecoxib:
- Correct volume status in dehydrated or hypovolemic patients 1
- Assess baseline renal function, particularly in patients with GFR 35-60 mL/min (where celecoxib AUC is 40% lower) 1
- Identify high-risk features listed above
During celecoxib therapy:
- Monitor renal function regularly in patients with renal/hepatic impairment, heart failure, dehydration, or hypovolemia 1
- Monitor blood pressure, as sodium retention can occur 9
- Watch for hyperkalemia, which can develop even in patients with normal renal function 1
Avoid celecoxib entirely in:
- Patients with advanced renal disease (severe renal insufficiency) unless benefits clearly outweigh risks 1
- Patients with prostaglandin-dependent renal perfusion states 5
Key Caveats
The FDA label states that "no information is available from controlled clinical studies regarding the use of celecoxib capsules in patients with advanced renal disease" 1. Despite the potentially better renal profile compared to non-selective NSAIDs, celecoxib still carries class-effect nephrotoxicity risk. The 2007 AHA scientific statement emphasizes that COX inhibitors can lead to impaired renal perfusion, and renal function should be monitored especially in patients with preexisting hypertension, renal disease, and heart failure 9.
If acute kidney injury develops, immediately discontinue celecoxib 1. Recovery typically follows cessation, though some patients may require temporary dialysis support 3.